Page 1986

miR Scientific Announces Validation of its Urine Based, Non-Invasive Prostate Cancer Test Published in the Journal of Urology

0
miR Scientific logo

– Validated Data Reinforces Capability to Molecularly Detect and Characterize Prostate Cancer with Concurrent Sensitivity and Specificity of Over 91%

– Data Support Integration of Sentinel Prostate Test™ in Patient Care Settings and Decision-Making

– Adoption Based on Published Data Indicates High Impact to Vastly Improve Patient Outcomes and Reduce Unnecessary Interventions and Waste

NEW YORK, Aug. 10, 2020 /PRNewswire-HISPANIC PR WIRE/ — miR Scientific, LLC, a healthcare company whose purpose is to transform cancer management by providing early and highly accurate detection, characterization and monitoring of disease, today announced that validation data for its Sentinel Prostate Test™ a urine-based, non-invasive cancer test were published in the September issue of the Journal of Urology. These data show that miR Scientific’s platform can detect molecular evidence of prostate cancer with sensitivity of 94% and specificity of 92%, which translates to AUC of 0.98. When the cancer is diagnosed, the test further classifies the cancer as either low risk with sensitivity of 93% and specificity of 90%, which translates to AUC of 0.98, or critically, as high risk with sensitivity of 94% and specificity of 96%, which translates to AUC of 0.99. The publication highlights test results based on urinary exosomes that are isolated from a single specimen of regularly passed urine. Hundreds of specifically extracted small non-coding RNAs (sncRNA) are then interrogated in a high-throughput real-time PCR–based platform and analyzed with a proprietary classification algorithm.

miR Scientific logo

Prostate cancer is the most common cancer, the second leading cause of cancer death among men in the United States,i a major source of health inequity,ii and a massive disease burden borne by individuals, their families, strained health systems and payors, including from public, private and employer-based sources. Today, despite the dedication and capabilities of primary care physicians, urologists and oncologists, patients are primarily subjected to a standard-of-care based on the forty-year old PSA test, which identifies a significant number of men as having elevated PSA, thereby potentially having prostate cancer, even though subsequent, highly invasive biopsies will prove that they do not have prostate cancer. Despite the variations on the cutoffs, the PSA test often fails to identify aggressive disease.iii This is a highly significant shortcoming as the patient only becomes aware of his cancer at later stages when mortality risk and treatment costs are far higher.   

“miR Scientific is dedicated to providing all age-eligible men, especially those with suspicion of cancer, a methodologically, clinically and scientifically validated technology that provides from a single urine specimen, exceptionally accurate, timely and actionable knowledge of the molecular status of prostate cancer,” said Sam Salman, Chairman & CEO. “Our breakthrough platform enables us to reimagine how things ought to be for patients, physicians and other key healthcare stakeholders: a standalone test that reaches across communities from all racial and socio-economic backgrounds with what is demonstrated in the Journal of Urology data to have an unmatched impact on comprehensively improved outcomes by optimizing care, reducing anxiety, eliminating avoidable morbidities and preserving life and precious financial and point-of-care resources.”

The publication includes performance data on a case-controlled training and validation group of 1,436 subjects comprised of a retrospective sample of 613 patients from the University Health Network at Princess Margaret Hospital’s GU BioBank and a cohort of 823 subjects from Albany Medical Center (AMC) and SUNY Downstate Medical Center (DMC), where urine samples were collected prior to biopsy and analyzed from participants with suspicion of prostate cancer, during a 2-year period (2017 to 2019). As further described in the publication, the testing and validation group was analyzed with sncRNA sequences obtained from a proprietary selection algorithm in a discovery phase comprised of a group of 235 participants from AMC and DMC.

“The miR Scientific Sentinel Test™ validation data in the Journal of Urology significantly contributes to the state-of-the-art innovation capabilities available to physicians. The scientists, researchers and biostatisticians involved in the creation of this breakthrough platform paid very close attention to the needs of physicians whose work always focuses on intervening at the earliest possible opportunity to provide life-saving care for patients harboring aggressive disease, and improving outcomes and quality of life for patients with indolent disease. I am proud to be among a leading cohort of physicians who will support the integration of the miR Scientific tests into clinical standards and practice,” said James McKiernan, MD, the John K. Lattimer Professor of Urology, and the chair of the Department of Urology of the College of Physicians and Surgeons and urologist-in-chief at NewYork-Presbyterian/Columbia.

The potential impact of definitive, accurate detection and classification of prostate cancer from a standalone, scalable, and non-invasive urine test is profound. With a single test, multiple key points of the traditional patient’s journey and continuum of care can be transformed into improved outcomes and quality of life. From a male population health perspective, the empirical data in the Journal of Urology publication supports measurable and sustained benefits to key stakeholders when adopted at scale. Applying the data to age-appropriate populations, it is expected that as a result of the early detection capability of the miR Scientific Sentinel tests, patient treatment outcomes shall improve, which often minimizes out-of-pocket costs. Similarly, since the publication’s data cohort includes the representative population found in large employer health plans, covered employees from all ethnicities and backgrounds can have the option to benefit from the miR Scientific Sentinel Test’s demonstrated rapid, reliable, accurate and safe assessment of prostate cancer risk and ongoing disease management. The demonstrated high specificity and sensitivity indicated in the data support the likely avoidance of wasteful costs and lost workdays that are otherwise incurred when unnecessary procedures and treatments are given to patients. As also supported by the data, with the ability of the miR Scientific Sentinel Test™ to identify high risk patients from those who do not have prostate cancer, or who have indolent disease, hospitals and clinics can benefit from safely prioritizing capacity and medical talent for those with high risk disease. Similarly, payors of all types are likely to process fewer reimbursement claims for unnecessary procedures and associated morbidities, by, for example, making active surveillance a more attractive option with a non-invasive test, and mitigating costs of supporting late-stage disease interventions.

Chairman & CEO Salman said that, based on the successful validation of each of its three standalone Sentinel test elements, miR Scientific has now taken the final step to generate a single, fully integrated Sentinel Prostate Test™ from a urine specimen collection that definitively classifies and monitors the risk of a subject into one of four groups: “No Molecular Evidence of Prostate Cancer” (NMEPC), or, for patients with molecular evidence of prostate cancer, Low Risk, Intermediate Risk, or High-Risk cancer.

The Company is preparing for the large-scale commercial launch of its Sentinel Prostate Test™ as a CLIA and CLEP Lab Developed Test.

About the miR Scientific Sentinel Prostate Assay

miR Scientific’s published paper in the Journal of Urology makes reference to three separately validated tests: the Sentinel PCa Test™, which determines whether or not there is molecular evidence of prostate cancer; the Sentinel CS Test,™ which for those with a positive Sentinel PCa Test™ (or other confirmatory cancer diagnosis), determines whether the cancer is low risk versus intermediate or high risk, and the Sentinel HG Test™, which for those with a positive Sentinel PCa Test™ (or other confirmatory cancer diagnosis), identifies patients with high grade, high risk cancer. Directly based on the validation of three tests in the referenced large Journal of Urology cohort, miR Scientific generated a single test that integrates the four possible outcomes based on a single urine specimen. The extraordinary sensitivity and specificity of the Sentinel tests enable them to be used non-invasively to screen, diagnose, prognose and monitor patients with prostate cancer without any other adjunctive test or analytic input such as a specific PSA, DRE or other value.

About miR Scientific

miR Scientific, LLC is a healthcare company whose purpose is to transform cancer management by providing early and highly accurate detection, characterization and monitoring of disease. Our team developed the miR Scientific Disease Management Platform™, which is comprised of proprietary, non-invasive and highly accurate liquid biopsy urine tests for the detection, classification and monitoring of urological cancers. miR Scientific is a majority-owned operating subsidiary of Impact NRS LLC, headquartered in New York with operating subsidiaries in Israel, Canada and Puerto Rico.

i https://www.cancer.gov/types/prostate 
ii Hoffman et al., 2001; Penner et al., 2012; DeSantis et al., 2016, 2019.
iii Joseph Presti, Jr. et al., Changes in Prostate Cancer Presentation Following the 2012 USPSTF Screening Statement: Observational Study in a Multispecialty Group Practice¸ 35(5) J. Gen. Intern. Med. 1368 (Dec. 2019).

Logo – https://mma.prnewswire.com/media/701096/miR_Scientific_Logo.jpg  

SOURCE miR Scientific, LLC

Anthem Foundation and March of Dimes Address Health Inequity in Maternal Healthcare

0
March of Dimes Foundation Logo

ARLINGTON, Va., Aug. 10, 2020 /PRNewswire-HISPANIC PR WIRE/ — March of Dimes, the leader in the fight for the health of all moms and babies, and longtime partner Anthem Foundation, the philanthropic arm of Anthem, Inc., today announced a $1.1 million grant with their latest plans to tackle America’s maternal and infant health crisis, which is particularly devastating for communities of color. The partnership aims to close the health equity gap by addressing the racial disparities and social determinants of health that have disproportionally impacted Black mothers who are more likely to die from pregnancy-related causes and have premature babies compared to all other women.

March of Dimes Foundation Logo

The new grant will support programs in 16 states and Washington D.C with a core component of the grant focusing on health equity partnerships with more than 20 hospitals, which includes Breaking Through Implicit Bias in Maternal Healthcare training. According to the 2003 National Academies for Science, Engineering and Medicine, “racial and ethnic minorities tend to receive a lower quality of healthcare than non-minorities, even when access-related factors, such as patients’ insurance status and income, are controlled.” In response, March of Dimes developed this training, in collaboration with Quality Interactions, to improve patient-provider communications and treatment decisions, contributing to improved quality of care at a critical intervention point. The course provides an overview of implicit bias, its impact on the maternal infant health crisis, history of structural racism in the United States, strategies for providers to both mitigate racial bias in maternity care and to commit to a culture of equity.

The grant will also support programs for moms and babies, such as Supportive Pregnancy Care and interconception care.  Through Supportive Pregnancy Care, pregnant women receive their clinical care, share support with other women at a similar stage in pregnancy, and gain knowledge and skills related to pregnancy, childbirth, and parenting. Interconception care programs help new moms to get information and services that promote birth spacing, smoking cessation, and mental health.

“The U.S. is in the midst of a maternal and infant health crisis, which is particularly devastating to women and babies of color. Data show that the U.S. remains among the most dangerous developed nations in the world for childbirth,” said Dr. Rahul Gupta, Chief Medical and Health Officer, Senior Vice President and Interim Chief Scientific Officer at March of Dimes. “Roughly every 12 hours a woman dies from pregnancy-related causes, and the CDC reports that 60 percent are preventable.  Programs like these, supported by the Anthem Foundation, are invaluable in making a positive impact for moms and babies.”

In the U.S. Black women are three times more likely to die from pregnancy-related causesi and Black babies are twice as likely to die before their first birthdaysii compared to their White counterparts. Systemic racial injustice has affected not only health care, but also social determinants of health, such as  access to food, education, housing and jobs. These factors, together with the direct experience of racial discrimination and unequal treatment, have built a health equity gap that is directly and negatively impacting moms and babies of color.

“Anthem and its Foundation continue to lead with our commitment to improving lives and communities across our nation,” said Razia Hashmi, MD, MPH, Vice President for Commercial Clinical Operations at Anthem. “For over 10 years, our partnership with March of Dimes has provided over 47,000 individuals with access to care. We are working tirelessly to create enduring change in communities across the country, and addressing the factors driving disparities in our health system and in society as a whole.”

Over the past decade, Anthem Foundation has contributed close to $8 million to support March of Dimes programs aimed at reducing premature birth across the country. These programs have had a significant impact with only 7.3 percent of participants in group prenatal care delivering prematurely, compared to a national average of 10 percent.

About March of Dimes
March of Dimes leads the fight for the health of all moms and babies. We support research, lead programs and provide education and advocacy so that every baby can have the best possible start. Building on a successful 80-year legacy of impact and innovation, we empower every mom and every family. Visit marchofdimes.org or nacersano.org for more information. Visit shareyourstory.org for comfort and support. Find us on Facebook and follow us on Instagram and Twitter.

About Anthem Foundation
The Anthem Foundation is the philanthropic arm of Anthem, Inc. and through charitable contributions and programs, the Foundation promotes the organization’s commitment to improving lives and communities. Through strategic partnerships and programs, the Foundation addresses the social drivers that will help create a healthier generation of Americans in communities that Anthem, Inc. and its affiliated health plans serve.  The Foundation focuses its funding on critical initiatives that make up its Healthy Generations Program, a multi-generational initiative that targets: maternal health, diabetes prevention, cancer prevention, heart health and healthy, active lifestyles, behavioral health efforts and programs that benefit people with disabilities. The Foundation also coordinates the company’s year-round Dollars for Dollars program which provides a 100 percent match of associates’ donations, as well as its Volunteer Time Off and Dollars for Doers community service programs. To learn more about the Anthem Foundation, please visit http://www.anthem.foundation and its blog at https://medium.com/anthemfoundation.

i [Petersen EE, Davis NL, Goodman D, et al. Racial/Ethnic Disparities in Pregnancy-Related Deaths-United States, 2007-2016. MMWR Morb Mortal Wkly Rep 2019;68(35):762–765.]↩
ii [Ely DM, Driscoll AK. Infant mortality in the United States, 2017: Data from the period linked birth/infant death file. National Vital Statistics Reports, vol 68 no 10. Hyattsville, MD: National Center for Health Statistics. 2019.]↩

Logo – https://mma.prnewswire.com/media/513643/March_of_Dimes_Foundation_Logo.jpg

 

SOURCE March of Dimes

New Series Empowers Record Number of Latinx to Register to Vote for the 2020 Elections

0

WASHINGTON, Aug. 10, 2020 /PRNewswire-HISPANIC PR WIRE/ — Hispanic Communications Network (HCN)  (hcnmedia.com) / La Red Hispana (laredhispana.org), launched the fourth edition of its Culture of Health / Cultura de Salud national multimedia programming series in both Spanish and English. The 2020 series, with the title “VOTAMOS”, focuses on the important connection between civic participation and social determinants of health that affect the well-being of Latinx communities across the US.

The general election on November 3, 2020 represents the first time Latinx populations will be the largest racial or ethnic group in the country. With a record 32 million eligible voters, Latinx represent 13.3% of potential voters in this year’s Presidential election. However, of those 32 million, 15 to 18 million eligible Latinx voters have yet to fully participate in the political process.

“This year’s Cultura de Salud-VOTAMOS programming series educates the public about the direct relationship between civic participation and family-community wellbeing. Every VOTAMOS segment provides concrete examples of how each person’s vote — and the outcomes of each election — make a clear difference in people’s daily lives. This ranges from showing how voting and election results directly shape healthcare options and accessibility, to illustrating how public policy impacts an individual’s quality of life” said Alison Rodden, CEO of HCN.

To support the goals of the VOTAMOS programming series, the HCN creative team developed the character “Super M” for “Super Martes (Super Tuesday)”. Super M is a neighborhood superhero who spends his spare time promoting civic participation under the “new normal” during the pandemic. Super M encourages Latinx of all ages to register and vote, while also reminding audiences there are other ways to be civically engaged throughout the year.

Latinx members of US Congress and leaders of national organizations like League of United Latin American Citizens (LULAC), Voto Latino, Mi Familia Vota, Poder Latinx, and America’s Voice are also featured. Their contributions highlight important benefits derived from civic participation in matters of health, education, housing, environment/climate, jobs and the economy, and more.

For the first time, the 2020 Cultura de Salud series will feature content for bilingual Millennial and Gen Z audiences through HCN’s new LatinEQUIS platform (wearelatinequis.com), hosted by Andrea Marquez. LatinEQUIS programming includes a volunteer focus to engage Latinx youth and young adult audiences, as studies show that middle school students involved in community service are more likely to vote or apply for popularly elected positions themselves when they reach adulthood.

HCN is also launching a bilingual zipcode-based voter registration platform for interested audiences to start the electoral registration process. The voter registration platform is available via HCN’s LaRedHispana.org website and La Red Hispana social media channels, as well as mobile devices by texting VOTAMOS to 52886. Studies show that around 8 out of 10 people who have taken the step of registering are more likely to vote on Election Day.

The Cultura de Salud-VOTAMOS programming series, supported by the Robert Wood Johnson Foundation, will last 12 weeks through the end of October. Programming includes original audio, video and digital productions with personal testimonies and information on how audiences can be civically engaged in their communities both locally and nationally. Multimedia segments for VOTAMOS will be transmitted through HCN’s La Red Hispana network of more than 200 Spanish-language radio stations via its daily mini-programas and long-format programs, and on digital channels and social network channels of HCN, La Red Hispana and LatinEQUIS.

The public can access “VOTAMOS” programming and additional content in both Spanish and English through laredhispana.org and wearelatinequis.com.

About Hispanic Communications Network & La Red Hispana

Hispanic Communications Network -HCN- is the market’s leading radio communication service, dedicated to the production and distribution of educational and informational content for the Hispanic community in the United States. HCN is positioned to provide its clients and government collaborators and nonprofit organizations with effective solutions when it comes to producing and distributing media campaigns focused on service and the generation of wellbeing within Hispanic communities. To learn more visit: hcnmedia.com and Laredhispana.org.

About the Robert Wood Johnson Foundation

For more than 45 years the Robert Wood Johnson Foundation has worked to improve health and health care. We are working alongside others to build a national Culture of Health that provides everyone in America a fair and just opportunity for health and well-being. For more information, visit www.rwjf.org. Follow the Foundation on Twitter at www.rwjf.org/twitter or on Facebook at www.rwjf.org/facebook.

CONTACT: Veronica Mayer 
(703) 566-3037

 

SOURCE Hispanic Communications Network

Hyundai Motor Announces IONIQ Brand Dedicated to EVs, Opening New Chapter for Customer-Centric EV Experiences

0
Hyundai Motor Announces IONIQ Brand Dedicated to EVs, Opening New Chapter for Customer-Centric EV Experiences

SEOUL, South Korea, Aug. 9, 2020 /PRNewswire-HISPANIC PR WIRE/ — Hyundai Motor Company today announced the launch of its new IONIQ brand dedicated to battery electric vehicles, opening a new chapter as a leader in the era of electrified mobility. Under the IONIQ brand, Hyundai will offer customer centric EV experiences centered on connected lifestyle solutions in line with Hyundai’s vision of ‘Progress for Humanity’.

Hyundai Motor Announces IONIQ Brand Dedicated to EVs, Opening New Chapter for Customer-Centric EV Experiences

Under the IONIQ brand, Hyundai Motor will leverage its industry-leading manufacturing know-how in EVs to introduce three new dedicated models over the next four years with more innovative models to follow. The creation of IONIQ brand is in response to fast-growing market demand and accelerates Hyundai’s plan to lead the global EV market.

To fulfill IONIQ’s brand mission, Hyundai will combine its current EV capabilities – such as ultra-fast charging, spacious interior, and battery-supplied power – with future innovations that combine design, technologies and services to integrate in-car and out-of-car experiences for a seamless journey.  

“The IONIQ brand will change the paradigm of EV customer experience,” said Wonhong Cho, Executive Vice President and Global Chief Marketing Officer at Hyundai Motor Company. “With a new emphasis on connected living, we will offer electrified experiences integral to an eco-friendly lifestyle.”

Rebirth of IONIQ

Hyundai first introduced the term IONIQ, which fuses “ion” and “unique”, when it announced Project IONIQ, a long-term research and development project focused on eco-friendly mobility. Based on the project, Hyundai in 2016 introduced a vehicle named IONIQ, the world’s first and only model to offer a choice of three electrified powertrain options – hybrid electric, plug-in hybrid and battery electric – within a single body type. Now, IONIQ represents Hyundai’s growing commitment to sustainability and innovation and will be instrumental in achieving the company’s clean mobility goals.

IONIQ brand was conceived to fuse life changing mobility with environmental performance and has so far been instrumental in delivering progress electrified. IONIQ will continue to create a new balance in clean mobility synchronizing eco-products within an eco-system of lifestyle solutions bringing connected living to a new generation.  

IONIQ 5 / IONIQ 6 / IONIQ 7

Hyundai will be launching a range of numerically named EVs under the new brand, with the even numbers used for sedans and the odd numbers for SUVs.

The first model under the IONIQ brand will be the IONIQ 5 midsize CUV that will launch in early 2021. IONIQ 5 is based on the concept EV ’45’, which Hyundai unveiled at the International Motor Show (IAA) 2019 in Frankfurt as a homage to its very first concept car. IONIQ 5’s designers took inspiration from the past and integrated it with cutting-edge parametric pixels, a unique design element that Hyundai designers will continue to incorporate into future IONIQ models.

In 2022, Hyundai will introduce IONIQ 6 sedan, which is based on the company’s latest concept EV ‘Prophecy’, unveiled in March; followed by IONIQ 7, a large SUV in early 2024. Prophecy’s iconic exterior design is characterized by its aerodynamic silhouette of perfect proportions.

Likewise, IONIQ vehicles’ designs will have a common theme of ‘Timeless Value’. The vehicles will be inspired by past models, but they will be a bridge to the future.

E-GMP platform

IONIQ brand models will sit on an Electric Global Modular Platform, known as E-GMP, that will enable fast charging capability and plentiful driving range.

The EV-dedicated platform will allow Hyundai to reimagine the vehicle interior as “smart living space” with highly adjustable seats, wireless connectivity and unique features such as a glove box designed as drawers. The platform paradigm shift will extend into the user interfaces that will be simple, intuitive and ergonomically designed to help occupants feel at ease.

Strategy 2025

Hyundai Motor Group recently announced that the group aims to sell 1 million units of battery electric vehicles and take 10 percent share to become a leader in the global EV field by 2025.

Under Strategy 2025, Hyundai Motor Company itself aims to become the world’s third-largest automaker of eco-friendly vehicles by 2025, with 560,000 BEV sales in addition to FCEV sales.

The launch of the IONIQ brand dedicated to EV models reinforces the company’s commitment to clean mobility and reflects its ongoing transformation as a Smart Mobility Solution Provider with zero-emissions solutions.

London Eye Event: IONIQ Campaign

Hyundai has celebrated the launch of IONIQ by turning the London Eye into a giant letter “Q” using electric lights just before the official reopening of the famous attraction.

This marks the first event of the ‘I’m in Charge’ brand campaign, which promotes empowerment of the environment and diverse lifestyles through IONIQ.

With the otherwise bustling city of London having come to a halt during the COVID-19 pandemic, Hyundai is bringing new energy into the city by lighting up and turning on one of its most iconic sights once again.

By announcing the arrival of IONIQ, Hyundai’s light installation heralds a new era of electrified mobility that puts customers at the center.

A video of Hyundai turning the globally famous London Eye into a huge ‘Q’ can be viewed here: https://youtu.be/PL1scZfgrDA.

Information about IONIQ Brand can be found at: www.hyundai.com/worldwide/en/brand/ioniq-launch 

About Hyundai Motor Company
Established in 1967, Hyundai Motor Company offers a range of world-class vehicles and mobility services in more than 200 countries. Hyundai Motor sold more than 4.4 million vehicles globally in 2019, and currently employs some 120,000 personnel worldwide. The company is enhancing its product lineup with vehicles designed to help usher in a more sustainable future, while offering innovative solutions to real-world mobility challenges. Through the process Hyundai aims to facilitate ‘Progress for Humanity’ with smart mobility solutions that vitalize connections between people and provide quality time to its customers.

More information about Hyundai Motor and its products can be found at: http://worldwide.hyundai.com or http://globalpr.hyundai.com

Disclaimer: Hyundai Motor Company believes the information contained herein to be accurate at the time of release. However, the company may upload new or updated information if required and assumes that it is not liable for the accuracy of any information interpreted and used by the reader.

Hyundai Motor Announces IONIQ Brand Dedicated to EVs, Opening New Chapter for Customer-Centric EV Experiences

Hyundai Motor Announces IONIQ Brand Dedicated to EVs, Opening New Chapter for Customer-Centric EV Experiences

Hyundai Motor America.

  

Photo – https://mma.prnewswire.com/media/1225597/Hyundai_Announces_IONIQ_Brand_Dedicated_to_EVs_1.jpg

Photo –https://mma.prnewswire.com/media/1225598/Hyundai_Announces_IONIQ_Brand_Dedicated_to_EVs_2.jpg

Photo – https://mma.prnewswire.com/media/1225599/Hyundai_Announces_IONIQ_Brand_Dedicated_to_EVs_3.jpg

Logo – https://mma.prnewswire.com/media/567096/Hyundai_Motor_America_Logo.jpg

Photo – https://mma.prnewswire.com/media/1225600/Hyundai_Announces_IONIQ_Brand_Dedicated_to_EVs_4.jpg

SOURCE Hyundai Motor America

(Español) Miami FC y UNANIMO Deportes lanzan asociación para promover el fútbol

0
Tomas Granitto - Miami FC

Sorry, this entry is only available in Español.

New tool compares rates of severe pregnancy complications across U.S. hospitals

0

BETHESDA, Maryland, Aug. 7, 2020 /PRNewswire-HISPANIC PR WIRE/ —

WHAT:
NIH-funded researchers have developed a new system for classifying severe maternal morbidity—life-threatening complications associated with childbirth—across U.S. hospitals. The system relies on patient discharge data to compare rates of severe maternal morbidity between different hospitals and different groups of patients. The study was led by Stephanie A. Leonard, Ph.D., of the Stanford University School of Medicine and appears in the journal Obstetrics & Gynecology. Funding was provided in part by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and National Institute of Nursing Research.

In the United States, rates of severe maternal morbidity are rising for all women and are worse among racial and ethnic minorities. Researchers studying severe maternal morbidity lack reliable ways to compare rates between groups with different underlying health statuses. According to the study authors, the new scoring system offers an advantage over current approaches. It also relies on U.S. patient discharge data, which is more readily available than electronic health records.

The study team developed and validated their tool using patient discharge data for all 919,546 live births in licensed hospitals in California from 2016 to 2017. The new system also evaluates a woman’s risk for severe birth complications independent of her risk from blood transfusions alone, which tend to be less severe than other complications. These two categories match how the Centers for Disease Control and Prevention and other public health professionals track maternal morbidity. With the new tool, scores range from 1 to 59 for severe maternal morbidity and 1 to 36 for non-transfusion severe maternal morbidity. The study team hopes that the new system will aid maternal health research and efforts to improve maternal health across the country.  

ARTICLE:
Leonard, SA, et al. An expanded obstetric comorbidity scoring system for predicting severe maternal morbidity. Obstetrics & Gynecology DOI: 10.1097/AOG.0000000000004022 (2020)

About the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): NICHD leads research and training to understand human development, improve reproductive health, enhance the lives of children and adolescents, and optimize abilities for all. For more information, visit https://www.nichd.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit https://www.nih.gov.

SOURCE Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health (NIH)

BD Announces Voluntary Recall of ChloraPrep™ 3 mL Applicator in Specific U.S. Territories and Countries

0
BD_Logo

FRANKLIN LAKES, New Jersey, Aug. 7, 2020 /PRNewswire-HISPANIC PR WIRE/ — BD (Becton, Dickinson and Company), a leading global medical technology company, announced a voluntary recall on June 23, 2020 for specified catalog numbers of the ChloraPrep™ 3 mL applicator due to possible fungal contamination, which only affects climate zone IV regions in specific U.S. territories and countries (see list of catalog numbers and regions impacted by this issue below).

BD has identified that storage of the ChloraPrep™ 3 mL Applicator in regions of the world with high heat and humidity, where product may be consistently exposed to temperatures of 30 degrees Celsius (86 degrees Fahrenheit) and 75% relative humidity for more than six months, may result in the growth of Aspergillus penicillioides. The recall does not apply to any states in the United States, it only applies to the U.S. territories of Puerto Rico, Guam, U.S. Virgin Islands, Northern Mariana Islands and American Samoa.

This recall does not include 3 mL applicators found in kits. It also does not include any other ChloraPrep™ product presentations. All other ChloraPrep™ products are manufactured with different packaging materials that are not affected by this issue.

As part of the voluntary recall to the user level, the company notified customers and distributors affected by the recall and provided guidance on the potential impact when the affected products were used.

Through internal product quality testing, BD has identified that storage of the ChloraPrep™ 3 mL Applicators where product may be consistently exposed to temperatures of 30 degrees Celsius (86 degrees Fahrenheit) and 75% relative humidity for more than six months can result in the growth of Aspergillus penicillioides, a type of fungus, resulting in a breach in the outer package integrity.

The Aspergillus penicillioides within the packaging can contaminate the surface of the applicator and/or gloved hands of the health care professional and then consequently the sterile field. Contamination of skin preparation products with Aspergillus penicillioides may lead to serious systemic infection, sepsis, illness and death. If the fungus is introduced into the patient’s bloodstream during placement of an intravascular catheter, the catheter would most likely have to be removed, necessitating another procedure. Aspergillus penicillioides infection of a surgical site may result in the need for medical and surgical interventions and long-term treatment with antifungal drugs.

To date, no complaints, adverse events, injuries or deaths have been reported related to this voluntary recall.

At the time of the recall, BD informed customers and distributors in the affected territories to discard all remaining inventory of the impacted ChloraPrep™ 3 mL applicators (see list of impacted catalog numbers below) and committed to replacing product affected by the recall.

Affected U.S. Territories/Countries

American Samoa

Nicaragua

Bahrain

Northern Mariana Islands

Brazil

Oman

Colombia

Panama

Costa Rica

Paraguay

El Salvador

Puerto Rico

Guam

Qatar

Guatemala

Saudi Arabia

Hong Kong

Singapore

India

United Arab Emirates

Kuwait

U.S. Virgin Islands

 

 

Affected Catalog Numbers in U.S. Territories

260400

ChloraPrep® One-Step 3 mL Applicator – Clear

260415

ChloraPrep® One-Step 3 mL Applicator – Hi-Lite Orange

930400

BD ChloraPrep™ Clear 3 mL Applicator

930415

BD ChloraPrep™ Hi-Lite Orange™ 3 mL Applicator

This recall is limited to the U.S. territories and countries listed above. This recall does not affect any other ChloraPrep™ product presentations, regardless of geography.

Customer inquiries related to this recall, as well as adverse reaction/events experienced with the product should be addressed to BD Customer Support: 1-800-526-4455 (Toll Free) between the hours of 8:30 a.m. and 6 p.m. ET.

FDA MedWatch Reporting
Adverse reactions/events experienced with the use of any of these products should also be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com.

Logo – https://mma.prnewswire.com/media/617615/BD_Logo.jpg

SOURCE BD (Becton, Dickinson and Company)

Music superstars to “take the stage” during virtual festival for St. Jude Children’s Research Hospital

0
St. Jude Children's Research Hospital Logo

MEMPHIS, Tennessee, Aug. 7, 2020 /PRNewswire-HISPANIC PR WIRE/ — Music’s biggest names in pop, R&B, country, Latin, indie, Gospel and more will unite to support St. Jude Children’s Research Hospital®️ for a virtual festival called Music Gives: Together #forStJude, on Thursday, Aug. 13, at 5 p.m. ET. The livestream will have all the makings of a summertime celebration – great music, delicious food and special edition souvenirs – with content across six stages to help raise awareness and support for the lifesaving mission of St. Jude: Finding cures. Saving children.®

St. Jude Children's Research Hospital Logo

In addition to music spanning multiple genres, the concert will include intermissions with culinary content from some of America’s most recognized chefs to make at home and enjoy during the festivities. Viewers can tune in and watch on Facebook, YouTube, Instagram and TikTok with additional announcements on Twitter.

The event will feature performances and special appearances by ABIR, AJ Rafael, Anthony Brown, Anthony Hamilton, Bobby Bones, Brad Paisley, Brett Eldredge, Cathy and Patrick Warburton, Cash Cash, CeCe Winans, Chef Lorena Garcia, Chef John Mitzewich, Chef Seamus Mullen, Chef Yisus, Coco Quinn, Darius Rucker, Drew Holcomb, For King & Country, Hot Chelle Rae, Jason Mraz, John McLaughlin, JD McCrary, Johnnyswimm, Jon Secada, Keith Urban, Kirk Franklin, La Energia Norteña, Lady A, Luis Fonsi, MAJOR., Mali Music, MercyMe, Natalia Jimenez, Randy Owen with ALABAMA, Pepa (Sandra Denton), Seal, Skillet, Tim McGraw, Third Eye Blind, Tye Tribbett and Us the Duo. The event will be hosted by Zach Sang, Montell Jordan, Frank Kramer, Omar Velasco and Argelia Atilano, former St. Jude patients Lindsey and Joel Alsup and CMT’s Cody and Marley. Lineup additions will be announced on @StJude social media channels.

“Summertime often brings people together for a favorite pastime: music festivals. During this time of social distancing, the incredible ambassadors and celebrity friends of St. Jude are ensuring that our summer does not go by without one, and leveraging their talent to make a huge difference for the children of the world,” said Richard C. Shadyac, Jr., President and CEO of ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital. “At St. Jude, we are reminded that when we all come together to give for those who need it most, we can make a significant difference, which is why I hope you’ll join us for Music Gives: Together #forStJude on August 13 – six hours total of incredible content and artists. Most importantly, giving through events like this when the world is so disrupted enables us to continue to ensure that families never receive a bill from St. Jude for treatment, travel, housing or food – because all a family should worry about is helping their child live.”

To purchase limited edition event merchandise, visit Design by Humans at dbh.la/stjudetogether. To learn more about the event, visit stjude.org/musictogether, join the waiting room at youtube.com/stjude, and follow @StJude social media channels for real-time updates about star talent added to the lineup. This event is powered by First Tube Media, an always-on live content platform designed to deliver premium video content and must-watch live cultural moments in a safe setting.

About St. Jude Children’s Research Hospital®
St. Jude Children’s Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. Its purpose is clear: Finding cures. Saving children.® It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments invented at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to more than 80 percent since the hospital opened more than 50 years ago. St. Jude won’t stop until no child dies from cancer. St. Jude freely shares the discoveries it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing or food – because all a family should worry about is helping their child live. Join the St. Jude mission by visiting stjude.org, liking St. Jude on Facebook, following St. Jude on Twitter, Instagram and TikTok, and subscribing to its YouTube channel.

Logo – https://mma.prnewswire.com/media/613525/St_Jude_Childrens_Research_Hospital_Logo.jpg

SOURCE ALSAC/St. Jude Children’s Research Hospital

Panda Express® Partners with Actor Dakota Fanning for Annual Panda Cares Day™ Celebration in Support of Underserved Youth in Health and Education

0
Actor Dakota Fanning Reads "All Are Welcome" by Author Alexandra Penfold & illustrator Suzanne Kaufman as Part of Panda Cares Day™ Celebration

ROSEMEAD, Calif., Aug. 7, 2020 /PRNewswire-HISPANIC PR WIRE/ — Following the establishment of its inaugural Panda Cares Day™ in 2019, Panda Cares®, the philanthropic arm of Panda Express®, commemorates its anniversary on August 8 every year with a celebration of giving back. In honor of the holiday this year, Panda partnered with actor and children’s advocate Dakota Fanning, to host a virtual storytime for children across the country at eight Children’s Miracle Network (CMN) Hospitals and 80 Boys & Girls Club of America (BGCA) chapters. Dakota surprised the children with a video message filled with words of encouragement, followed by a dedicated reading of “All Are Welcome” by author Alexandra Penfold & illustrator Suzanne Kaufman. For more than 20 years, Panda Cares’ vision has been to empower youth to learn, lead and thrive for brighter futures through health and education, creating powerful learning pathways and focused care for the holistic well-being of kids nationwide.

Actor Dakota Fanning Reads "All Are Welcome" by Author Alexandra Penfold & illustrator Suzanne Kaufman as Part of Panda Cares Day™ Celebration

BGCA drive-by parties and CMN Hospital visits took place at 88 locations in which Panda hosted the virtual storytime this week. As part of the celebrations, the organizations received a total of 88,000 books for the children, aimed at developing reading skills, enhancing critical thinking skills and broadening perspectives. In addition, curated through its Panda Cub Club™ enrichment initiative established earlier this year, Panda provided fun at-home activities to encourage learning through play. Both CMN Hospitals and BGCA are longtime partners of Panda Cares and have enabled the foundation to support millions of children and families over the years. 

“As a family business, we believe it is our responsibility to foster the spirit of kindness in our extended Panda family of guests and associates, and it has been an honor to witness everyone coming together to further our mission of inspiring better lives,” said Dr. Peggy Cherng, Co-Founder and Co-CEO of Panda Express. “Panda Cares Day has a special place in our hearts for many reasons. The number 8 is the luckiest number in the Chinese culture, representing prosperity. The number is thought to bring good fortune in life, which is why we established Panda Cares Day on August 8—to share good fortune with the communities we serve.”

Following a commitment of $25 million to Children’s Miracle Network Hospitals to fund Panda Cares Centers of Hope in 2019, Panda Cares unveils its 8th Center of Hope on Panda Cares Day 2020 at Lurie Children’s Hospital in Chicago, Illinois, which is serendipitously celebrating its 8th anniversary this year. The Panda Cares Center of Hope inspires hope and promotes healing by providing specially curated programs that address each child’s entire well-being, including their physical, emotional, mental, and spiritual needs. Therapeutic play, art therapy, and counseling services are just a few examples of a wide range of offerings at Panda Cares Center of Hope designed to give children the courage and strength to thrive. Since last year, Panda and CMN Hospitals have debuted Center of Hope locations across several hospitals in the U.S. including California, Texas, Nevada, Hawaii, Washington D.C., and Arizona.

To extend the festivities to its guests, the American Chinese brand has organized a virtual fundraiser on August 8, to continue to drive donations to support children in underserved communities. When a guest places an order on the Panda Express mobile app or website using the promo code ‘PandaCaresDay,’ Panda Express will donate 28 percent of the pre-tax sales to their local CMN hospital.

Panda Cares is funded through the in-store and online donation box program and associates at Panda Express, Panda Inn, and Hibachi-San as well as Panda Restaurant Group partners and founders. The foundation provides food, funding and volunteer services to underserved youth, and disaster relief efforts. For more information about Panda Cares, please visit PandaCares.org. For media inquiries, please contact [email protected].  

About Panda Express®
On a mission to inspire better lives, Panda Express® is the largest Asian dining concept in the U.S. Family-owned and operated since 1983 by co-founders and co-CEOs Andrew and Peggy Cherng, Panda Express is best known as a trailblazer for creating a wide variety of industry-first recipes, including its best seller the Original Orange Chicken® and award-winning Honey Walnut Shrimp™, which have defined the category of authentic American Chinese cuisine. Each dish at Panda Express is thoughtfully crafted with quality ingredients and inspired by bold Chinese flavors and culinary principles. The restaurant brand has more than 2,200 locations and has introduced American Chinese cuisine to twelve international countries. Powered by this global family of associates, Panda Cares®, Panda’s philanthropic arm, has raised more than $216 million and dedicated countless volunteer hours in bettering the health and education for over 12 million youths, as well as supporting communities in need since 1999. In 2020, the organization established the Panda Cares Scholars Program to provide the necessary funding, academic support and leadership development to help high school and college students learn, lead and thrive towards a bright future. For more information about Panda, visit pandaexpress.com, or find us on Facebook, Twitter or Instagram. 

Unveiling of Panda Cares Center of Hope at Lurie Children's Hospital in Chicago, IL

 

Patients at Lurie Children's Hospital Enjoy a Surprise Reading from Actor Dakota Fanning in Honor of Panda Cares Day™

 

Photo – https://mma.prnewswire.com/media/1225349/PandaCaresDay_DakotaFanning_1.jpg
Photo – https://mma.prnewswire.com/media/1225350/Panda_Cares_Center_of_Hope.jpg
Photo – https://mma.prnewswire.com/media/1225352/Surprise_Reading.jpg
Logo – https://mma.prnewswire.com/media/1225351/Panda_Cares_Day_Lockup_Logo.jpg

SOURCE Panda Express

Ocean New Media, LLC Signs Multi-Series Deal With Entertainment One To Stream More Than 200 Hours Of Content On Free TV In LatAm

0

WEST PALM BEACH, Florida, Aug. 7, 2020 /PRNewswire-HISPANIC PR WIRE/ — Ocean New Media, LLC, owned by  Olympusat, Inc., one of the largest independent media companies specializing in the ownership, distribution, production and technical services of Spanish- and English-language networks, announced today it secured a multi-year licensing partnership with Entertainment One (eOne) to distribute more than 200 hours of its content on Olympusat newly launched AVOD service Free TV™ in LatAm. 

The deal spans eOne’s expansive catalogue including Bitten (seasons 1-3), Haven (seasons 1-5), Turn: Washington’s Spies (seasons 1-4), Rogue (seasons 1-4), Saving Hope (seasons 1-5), Matador (season 1), The Enfield Haunting (3-part series), Ice (seasons 1-2) and Klondike (3-part series).

“Entertainment One as a talent-driven independent Studio is home to one of the best original world-class artists and storytellers behind some of the most iconic characters and shows,” said Aurora Bacquerie, Senior Vice-President of Content Acquisition and Channels of Olympusat. “We believe the eOne catalog will really appeal to both our existing and new customers, as we continue to take FREE TV to more markets around the world.”

Series Descriptions

Bitten: Based on the New York Times best-selling novels by Kelley Armstrong, Bitten is set in a world where werewolves live undetected amongst humans. Laura Vandervoort (Smallville, Ted) stars as Elena Michaels, the world’s only female werewolf. The series follows Elena’s dangerous struggle between the new life she’s created and her loyalty to The Pack.

Haven: Haven, based on the Stephen King’s novella The Colorado Kid, is the story of FBI agent Audrey Parker (Emily Rose, Graceland) and her investigation of a seemingly normal seaside town. Across the seasons, Audrey’s quest to understand both herself and the great mysteries of Haven, a town harbouring dark and mysterious secrets, will drive her even deeper down the supernatural rabbit hole.

Turn: Washington’s Spies: In the treacherous and volatile Revolutionary War, unassuming farmer Abraham Woodhull (Jamie Bell, Billy Elliot) and his friends form America’s first spy ring, turning the tide in the country’s battle for independence.

Rogue: Starring Thandie Newton (Westworld), Rogue revolves around Grace (Newton), a morally and emotionally conflicted undercover detective who is tormented by the possibility that her own actions contributed to a family tragedy. Grace’s search for the truth is further complicated by her forbidden relationship with Jimmy (Marton Csokas, The Luminaries), the crime boss who may have played a hand in the crime. The series explores loss, grief, identity, family bonds, second chances and redemption.

Saving Hope: In Saving Hope, the Hope Zion Hospital is left in chaos when its charismatic Chief of Surgery, Charlie Harris (Michael Shanks, Altered Carbon), falls into a coma, putting his fiancé and fellow surgeon, Alex Reid (Erica Durance, Supergirl), in a state of shock. Along with newly arrived star surgeon, Joel Goran (Daniel Gillies, The Originals), Reid races to save Harris’ life. As the action unfolds, the comatose Harris explores the hospital halls in the form of a spirit, questioning whether or not he is a figment of his own imagination. 

Matador: The irreverent, adrenaline-filled series chronicles the unlikely rise of Tony “Matador” Bravo (Gabriel Luna, Agents of S.H.I.E.L.D.), a professional soccer player for the LA Riot who comes to be known as much for his antics off the field as his moves on it. But what his fans and family don’t realize is that it’s all a cover—in truth, he is a skilled covert operative executing missions for the CIA.  Agent Bravo nicknamed “Matador” after he takes out a top player known as “The Bull” during try outs for the team, finds himself suddenly thrust into a clandestine world.  But, in balancing his duelling roles, he will be forced to confront the question of his true identity… and it is this mission which may prove to be his most dangerous. 

The Enfield Haunting: Adapted from Guy Lyon Playfair’s book “This House is Haunted,“ The Enfield Haunting draws on extensive documentation, recordings and witness statements recorded at the time. To this day, the incident remains the most documented account of poltergeist activity in British history and the basis of horror films including The Conjuring 2. The Enfield Haunting stars Timothy Spall (Harry Potter, The King’s Speech) as Maurice Grosse, a rookie paranormal researcher, BAFTA nominated actress Juliet Stevenson (Emma, Truly Madly Deeply) as Maurice’s wife Betty and award-winning actor Matthew Macfadyen (Ripper Street, Pride and Prejudice) as Playfair, an experienced investigator who approaches the case with skepticism. 

Ice:  Executive produced by Antoine Fuqua (The Magnificent Seven), Ice delves into the dark, gritty and dangerous underbelly of the diamond trade with an all-star cast featuring Cam Gigandet (Twilight, Easy A, The O.C.), Jeremy Sisto (Suburgatory, Law & Order), Ray Winstone (The Departed, The Sweeney) and Donald Sutherland (The Hunger Games series, Forsaken).

Klondike: Starring Richard Madden (Game of Thrones), Abbie Cornish (Tom Clancy’s Jack Ryan), Tim Roth (The Hateful Eight) and Sam Shepard (Bloodline), Klondike is an event mini-series of epic proportion inspired by the true stories of those who hunted for wealth and battled for survival in the brutal Yukon Territory. At the center of the action are Bill Haskell and Byron Epstein – childhood best friends who risk everything to pursue their dream of striking it rich during the 1890’s gold rush. Lured into this treacherous landscape by the prospect of riches, they endure the unforgiving elements and discover that the deadliest threats are always human.

The deal was brokered by David Hanono, VP Latin America, International Distribution, eOne.

About eOne
Entertainment One Ltd. (eOne) is a talent-driven independent studio that specializes in the development, acquisition, production, financing, distribution and sales of entertainment content. As part of global play and entertainment company Hasbro (NASDAQ: HAS), eOne’s expertise spans across film, television and music production and sales; family programming, merchandising and licensing; digital content; and live entertainment. Through its extensive reach and scale, and a deep commitment to high-quality entertainment, eOne unlocks the power and value of creativity.

eOne brings to market both original and existing content, sourcing IP from Hasbro’s portfolio of 1500+ brands, and through a diversified network of creative partners and eOne companies including: international feature film distribution company Sierra/Affinity; Amblin Partners with DreamWorks Studios, Participant Media, and Reliance Entertainment; Makeready with Brad Weston; unscripted television production companies Renegade 83, Daisybeck, Blackfin and Whizz Kid Entertainment; live entertainment leaders Round Room Live; world-class music companies Audio Network, Dualtone Music Group and Last Gang; and award-winning emerging content and technology studio Secret Location.
www.entertainmentone.com

About Olympusat:
Olympusat, Inc., based in West Palm Beach, Fla., is an established leader in the Hispanic television and media space through its HD Spanish-language and English-language premium television networks. It is one of the largest independent media corporations specializing in ownership, distribution, production and technical services with offerings that include the top-rated Spanish-language movie channel Cine Mexicano, the popular Ultra HD Plex, Faith & Family Suite and SVOD Suites representing some of the biggest networks in the industry. Content is comprised of original productions, dubbed content from Europe and Asia, and licensed in-language content from the U.S., Spain and Latin America. Olympusat provides Spanish dubbing services in its Mexico City facilities for the U.S. and Latin American Hispanic market. Recently has launched Free TV™ Application, the top Ad-Supported, On-Demand Video Service,  available in Latin-American market including Mexico, through Google Play Store, Apple Store, via Web Browser (at freetv.com), and mobile apps for Apple’s iOS as well as Google’s Android.
For more about Olympusat visit Olympusat.com

Olympusat – Media Contact:
Jesús Piñango
Senior Director of News
Email: [email protected]

SOURCE Ocean New Media, LLC

1...1,9851,9861,987...3,072Page 1,986 of 3,072
Copyright © 2016 PR Newswire Association LLC. All Rights Reserved. A Cision company.